Providing professional consulting and business development services to the medical, life sciences and pharmaceutical sectors:- Biosimilars/Biobetters, Biologics and bio-therapeutic based drugs.- Cell and Gene Therapy (CGT).Our current focus is Green Medicine; and disruptive tech development.

OmniaBio Inc., a subsidiary of Toronto-based CCRM, is a contract development and manufacturing organization (CDMO) producing gene-modified cells and viral vectors, compliant with current Good Manufacturing Practices (cGMP) standards.

Excellence in the business, science, development and manufacture of biologics.High Quality, Cost Effective Microbial Process Development and cGMP Manufacturing Solutions, from Preclinical to Commercial Supply. BioCina is a proven science-driven pharmaceutical CDMO, building upon it's Global quality reputation from our Adelaide AU GMP TGA, FDA, Health Canada, EMA approved facility; a state of art ultra modern microbial facility acquired from Pfizer, and proven commercial pharmaceutical experience.

Director of Business Development at GenScript ProBio; a leading CDMO in Biologics, Antibodies and Gene and Cell Therapy (GCT). Responsible for business development of the company's services and offerings in antibody development from preclinical to commerical, stable cell lines, gene and cell therapy including phase appropriate plasmid and virus. National responsibilities.

Led the development of the company’s technology and platforms, with lead projects focused in Immuno-Oncology (TNBC) , ALZ therapeutics development and companion diagnostics. Key technology relationships and due diligence.

Led cross-functional teams, built strong working relationships and advanced meaningful and strategic customer relationships with KOL’s Internationally across the Molecular Biology Business Segment with major International Research Consortia and Collaborative “Big Science” Programs: Business focus Affinity Reagents and Clinical Proteomics, Next Generation Sequencing (NGS), Clinical Genomics, Epigenetics and Stem Cells. Provided strategic input into the company’s business development activities and effectively conveyed recommendations to senior Executive leadership, led internal and external discussions with key stakeholders, and fostered executive level relationships with Major International Funding Agencies and Industry, working through a matrix report structure with Executive VP’s Molecular Biology Business Segment; R&D, Commercial Sales and Marketing. Created an effective innovation pipeline by developing Life Technologies’ scientific collaborations, and proprietary technology seeding into strategic growth sectors including:• Novel methodologies and advanced reagents for Pharmacogenomics, NGS and targeted medical re-sequencing• Preferred “scientific relationship” with the International Human Proteome Organization (HUPO); development of HUPO Proteomic Standards, Scientific Initiatives and Industrial Advisory Board (IAB)• Clinical Affinity Proteomics; International Ab Reagent programs, advanced MS instrumentation• International Stem Cell research programs; Canadian Stem Cell Network, International Stem Cell Regulome project (IRC), Asian Stem Cell Proteomics Initiatives (S.Korea, Japan), developing EU programs including Welcome Trust• Emerging Next Gen Genomics programs including: I-Bol - the International DNA Barcode Project, Phase II of the Structural Genomics Consortia (SGC), The International Human Microbiome Project

Duties• Managed and developed Account Managers in all Medical and Biotechnology accounts in Canada• Fulfilled regional and national commercial responsibilities. Ensured consistent above plan performance as Canadian Commercial Manager. Key member of senior leadership team.Key Achievements• Managed half the Canadian CAD$35-40M Commercial Plan/Team to consistent above plan performance• Closed the largest Canadian order by structuring, negotiating, and closing significant and complex deals in line with the company’s business development• Developed strategic market development initiatives for incremental revenue growth such as “Team Selling”• Drove consistent winning sales team(s)’ development and performance

Ensured consistent, above plan (double digit) sales/team performance. Developed key commercial LTI programs including: Account profiling, portfolio focus; key R&D areas, top portfolio analysis, "solutions" based selling, onsite Science/product Molecular Biology stores in Research institutes and Biotech accounts.

Pharmaceutical Sales - Physicians, Specialists and Pharmacies, Canada's first Generic Pharmaceutical Company; high value Rx pharmaceuticals.